Study aims to understand molecular origins of CTNNB1 neurodevelopmental syndrome

On the occasion of Rare Disease Day, the Biofisika Institute (CSIC, EHU) presents the progress of a project aimed at understanding the molecular origin of CTNNB1 neurodevelopmental syndrome, a rare disease caused by mutations in the beta-catenin protein. Although fewer than 50 cases of this pathology have been diagnosed in Spain, rare diseases affect a … Read more

Sub-terahertz biosensors enable label-free cancer cell identification

Early detection and accurate typing of cancer are critical for improving patient survival rates. While traditional pathology remains the gold standard, it often requires complex sample processing and chemical staining. In a study published in the journal PhotoniX, researchers from the State Key Laboratory of Millimeter Waves at Southeast University and the Zhongda Hospital of … Read more

Study shows red wine biomarkers in urine can predict inflammation levels

Scientists have uncovered how gut-derived compounds in urine can reveal red wine’s anti-inflammatory effects—offering a more accurate way to link diet to heart health. Short Communication: Microbiota-derived resveratrol metabolites: New biomarkers of red wine consumption are inversely associated with inflammation in a longitudinal study of a Mediterranean population. Image Credit: givaga / Shutterstock In a recent study … Read more

Changes to intermediate filament protein drives aggressive breast cancer growth

Changes to the intermediate filament (IF) protein, vimentin, were found to promote tumor growth by increasing cancer stemness in an estrogen independent manner. Targeting vimentin and/or the long noncoding RNA (lncRNA) ‘XIST’ could be an effective therapeutic strategy for treating aggressive breast cancer.  Vimentin is a type III intermediate filament (IF) protein normally expressed in … Read more